Uraemic Cardiomyopathy in Different Mouse Models
Open Access
- 14 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8, 690517
Abstract
Uraemic cardiomyopathy (UCM) is one of the most common complications in chronic kidney disease (CKD). Our aim was to compare characteristics of various UCM mouse models. Mice were assigned to the following groups: the pole ligation group, 5/6 nephrectomy group (5/6Nx), uninephrectomy plus contralateral ischemia followed by reperfusion group (IR), adenine group, and sham group. Mice were sacrificed at 4, 8, and 16 weeks after surgery in the pole ligation, 5/6Nx, and IR groups, respectively. In the adenine group, mice were sacrificed at 16 weeks after the adenine diet. The structure and function of the heart and the expression of fibroblast growth factor 23 (FGF-23) and growth differentiation factor 15 (GDF-15) in hearts were assessed. The mortality in the 5/6 Nx group was significantly higher than that in the pole ligation, IR, and adenine groups. Echocardiogram and histological examination showed cardiac hypertrophy in the adenine,5/6Nx, ligation group, and IR group. In addition, cardiac fibrosis occurred in all CKD modeling groups. Interestingly, cardiac fibrosis was more serious in the IR and adenine groups. FGF-23 expression in sham mice was similar to that in modeling groups; however, the GDF-15 level was decreased in modeling groups. Our results suggest that the four models of UCM show different phenotypical features, molding time and mortality. GDF-15 expression in the hearts of UCM mice was downregulated compared with sham group mice.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal diseaseNephrology Dialysis Transplantation, 2011
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Novel biomarkers in human terminal heart failure and under mechanical circulatory supportBiomarkers, 2011
- Public Health Consequences of Chronic Kidney DiseaseClinical Pharmacology & Therapeutics, 2009
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney DiseaseCirculation, 2009
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing HemodialysisNew England Journal of Medicine, 2008
- Partial nephrectomy as a model for uremic cardiomyopathy in the mouseAmerican Journal of Physiology-Renal Physiology, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- International Comparison of the Relationship of Chronic Kidney Disease Prevalence and ESRD RiskJournal of the American Society of Nephrology, 2006
- Central Role for the Cardiotonic Steroid Marinobufagenin in the Pathogenesis of Experimental Uremic CardiomyopathyHypertension, 2006